BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
OHSU Knight Cancer Institute
MacroGenics
DualityBio Inc.
ImmunityBio, Inc.
Mayo Clinic
Oslo University Hospital
Iovance Biotherapeutics, Inc.
Vyriad, Inc.
Providence Health & Services
Seagen Inc.
University of Pittsburgh
IO Biotech
Providence Health & Services
European Organisation for Research and Treatment of Cancer - EORTC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoag Memorial Hospital Presbyterian
National Cancer Institute (NCI)